Combined therapy with CTL cells and oncolytic adenovirus expressing IL-15-induced enhanced antitumor activity
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Combined therapy with CTL cells and oncolytic adenovirus expressing IL-15-induced enhanced antitumor activity
Authors
Keywords
CTL cells, IL-15, Oncolytic adenovirus
Journal
TUMOR BIOLOGY
Volume 36, Issue 6, Pages 4535-4543
Publisher
Springer Nature
Online
2015-01-27
DOI
10.1007/s13277-015-3098-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Manipulating immune cells for adoptive immunotherapy of cancer
- (2014) Phillip K Darcy et al. CURRENT OPINION IN IMMUNOLOGY
- Recent developments in oncolytic adenovirus-based immunotherapeutic agents for use against metastatic cancers
- (2013) I-K Choi et al. CANCER GENE THERAPY
- Interleukin-15 in Gene Therapy of Cancer
- (2013) Maria C. Ochoa et al. CURRENT GENE THERAPY
- Combination of E2F-1 promoter-regulated oncolytic adenovirus and cytokine-induced killer cells enhances the antitumor effects in an orthotopic rectal cancer model
- (2013) Yang Yan et al. TUMOR BIOLOGY
- Synergistic Interaction of Telomerase-Specific Oncolytic Virotherapy and Chemotherapeutic Agents for Human Cancer
- (2012) Toshiyoshi Fujiwara et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Oncolytic virotherapy
- (2012) Stephen J Russell et al. NATURE BIOTECHNOLOGY
- Combined Therapy with Cytokine-Induced Killer Cells and Oncolytic Adenovirus Expressing IL-12 Induce Enhanced Antitumor Activity in Liver Tumor Model
- (2012) Zhi Yang et al. PLoS One
- Evolution of oncolytic adenovirus for cancer treatment
- (2011) Joung-Woo Choi et al. ADVANCED DRUG DELIVERY REVIEWS
- Expressing human interleukin-15 from oncolytic vesicular stomatitis virus improves survival in a murine metastatic colon adenocarcinoma model through the enhancement of anti-tumor immunity
- (2011) K B Stephenson et al. CANCER GENE THERAPY
- Interleukin 15 as a promising candidate for tumor immunotherapy
- (2011) Marek Jakobisiak et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Optimizing DC Vaccination by Combination With Oncolytic Adenovirus Coexpressing IL-12 and GM-CSF
- (2011) Song-Nan Zhang et al. MOLECULAR THERAPY
- Cell transfer immunotherapy for metastatic solid cancer—what clinicians need to know
- (2011) Steven A. Rosenberg Nature Reviews Clinical Oncology
- Interleukin-15 and Its Receptor Augment Dendritic Cell Vaccination against the neu Oncogene through the Induction of Antibodies Partially Independent of CD4 Help
- (2010) J. C. Steel et al. CANCER RESEARCH
- Oncolytic viruses and histone deacetylase inhibitors—A multi-pronged strategy to target tumor cells
- (2010) Thi Lien-Anh Nguyen et al. CYTOKINE & GROWTH FACTOR REVIEWS
- IL-15 has innate anti-tumor activity independent of NK and CD8 T cells
- (2010) Elizabeth Davies et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Selectivity of Oncolytic Viral Replication Prevents Antiviral Immune Response and Toxicity, but Does Not Improve Antitumoral Immunity
- (2010) Engin Gürlevik et al. MOLECULAR THERAPY
- Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
- (2010) Philip W. Kantoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Enhancement of tumor cell death by combining cisplatin with an oncolytic adenovirus carrying MDA-7/IL-24
- (2009) Yu-mei Wu et al. ACTA PHARMACOLOGICA SINICA
- Armed replicating adenoviruses for cancer virotherapy
- (2009) J J Cody et al. CANCER GENE THERAPY
- IL15 Can Reverse the Unresponsiveness of Wilms' Tumor Antigen-Specific CTL in Patients with Prostate Cancer
- (2009) J. W. King et al. CLINICAL CANCER RESEARCH
- Oncolytic Adenovirus: Preclinical and Clinical Studies in Patients with Human Malignant Gliomas
- (2009) Hong Jiang et al. CURRENT GENE THERAPY
- Myxoma Virus Expressing Interleukin-15 Fails To Cause Lethal Myxomatosis in European Rabbits
- (2009) J. Liu et al. JOURNAL OF VIROLOGY
- Oncolytic viruses: a novel form of immunotherapy
- (2008) Robin J Prestwich et al. Expert Review of Anticancer Therapy
- A phase II study of adoptive immunotherapy using dendritic cells pulsed with tumor lysate in patients with hepatocellular carcinoma
- (2008) Daniel H. Palmer et al. HEPATOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More